Z. Cheng, T. Zhang, W. Wang et al.
Chinese Chemical Letters 32 (2021) 1580–1585
Fig. 4. (a) Tumor growth and (b) bodyweight changes of three groups with different treatments. (c) Photographs of three groups tumor-bearing mice after treatment. (d) The
mice tumors collected with Group I and Group II. (e) H&E stained images of the tumor tissues after treatment. Scale bar: 100 m.
m
biosafety and low side toxic effect of SeBTT NPs. All the results
demonstrate that SeBTT NPs can serve as an excellent nano-agent
for PTT. After 16-days treatment in vivo, the mice in all groups were
executed, and the tissues of tumor and main organs were collected
for histopathological examination using hematoxylin and eosin
to the High-Performance Computing Center in Nanjing Tech
University for supporting the computational resources.
Appendix A. Supplementary data
(
H&E) staining to comprehend the therapeutic efficacy at cellular
level. Fig. 4e records the photographs of the tumor histologic
section of Group I and Group II. It is found that the tumor cells are
arranged closely, and the nuclei of tumor cells are in good order.
Moreover, the H&E staining of main organs from different
treatment groups illustrates that there is no noticeable damage
of histological morphology of the groups with SeBTT NPs injection,
comparing to the PBS injection group (Fig. S11 in Supporting
information). The photography of the organs shows that the cells’
nuclear remains almost unchanged. All results indicate that SeBTT
NPs are equipped with a high bio-compatibility without any
noticeable side effects to living mice in vivo.
References
[1] H.S. Jung, P. Verwilst, A. Sharma, et al., Chem. Soc. Rev. 47 (2018) 2280–2297.
[2] G. Feng, G.Q. Zhang, D. Ding, Chem. Soc. Rev. 49 (2020) 8179–8234.
[3] D. Chen, Z. Zhong, Q. Ma, et al., ACS Appl. Mater. Interfaces 12 (2020) 26914–
26925.
[4] W. Hu, X. Miao, H. Tao, et al., ACS Nano 13 (2019) 12006–12014.
[5] M. Chen, X. Zhang, J. Liu, et al., ACS Nano 14 (2020) 4265–4275.
[6] Y. Cai, W. Si, W. Huang, et al., Small 14 (2018) 1704247.
[7] Y. Xiao, F. An, J. Chen, et al., Small 15 (2019) 1903121.
[8] Q. Xia, Z. Chen, Z. Yu, et al., ACS Appl. Mater. Interfaces 10 (2018) 17081–17088.
[9] J. Weber, P.C. Beard, S.E. Bohndiek, Nat. Methods 13 (2016) 639–650.
In summary, two near-infrared absorbing organic small
molecular dyes SeBTT and BBTT were developed through D-A-D
structural design, and showed intensive NIR absorbance and high
molar extinction coefficient. Hydrophilic SeBTT NPs and BBTT NPs
were obtained after nano-precipitation and showing remarkable
photothermal conversion efficacy of 65.3% and 55.1%, respectively.
In vitro experiments illustrate that both SeBTT NPs and BBTT NPs
can effectively kill the HeLa cells in a dose-dependent manner with
[
10] A. de la Zerda, S. Bodapati, R. Teed, et al., ACS Nano 6 (2012) 4694–4701.
[11] J. Li, K. Pu, Chem. Soc. Rev. 48 (2019) 38–71.
[12] Y. Jiang, P.K. Upputuri, C. Xie, et al., Adv. Mater. 31 (2019) 1808166.
[13] D. Cui, P. Li, X. Zhen, et al., Adv. Funct. Mater. 29 (2019) 1903461.
[14] Z. Wang, P.K. Upputuri, X. Zhen, et al., Nano Res. 12 (2019) 49–55.
[15] Y. Chen, L. Li, W. Chen, H. Chen, J. Yin, Chin. Chem. Lett. 30 (2019) 1353–1360.
[16] W. Hu, P.N. Prasad, W. Huang, Acc. Chem. Res. 54 (2020) 697–706.
[
[
17] X. Yang, G. Liu, Y. Shi, et al., Nanotechnology 29 (2018) 222001.
18] L. Cheng, C. Wang, L. Feng, K. Yang, Z. Liu, Chem. Rev. 114 (2014) 10869–10939.
[
19] Y. Yang, Y. Yu, H. Chen, et al., ACS Nano 14 (2020) 13536–13547.
[20] P. Liang, Q. Tang, Y. Cai, et al., Chem. Sci. 8 (2017) 7457–7463.
21] X. Gu, X. Zhang, H. Ma, et al., Adv. Mater. 30 (2018) 1801065.
low half-maximal inhibitory concentration (IC50) of 20
mg/mL and
[
25 m
g/mL, respectively. With a xenograft HeLa tumor-bearing nude
[22] J. Qi, C. Chen, X. Zhang, et al., Nat. Commun. 9 (2018) 1848.
mouse model, photoacoustic imaging-guided photothermal ther-
apy is studied for SeBTT NPs, which illustrate that SeBTT NPs can
efficiently kill the tumors in living mice without noticeable side
effect to main organs. It is suggested that molecular surgery
strategy through heteroatom substitution is effective to regulate
the photothermal properties of NIR small molecules for enhanced
photoacoustic imaging and photothermal therapy.
[
23] N. Shi, Y. Shi, J. Shao, et al., Dyes Pigm. 160 (2019) 683–691.
[24] H.S. Jung, J.H. Lee, K. Kim, et al., J. Am. Chem. Soc. 139 (2017) 9972–9978.
[
[
25] H.S. Jung, J. Han, J.H. Lee, et al., J. Am. Chem. Soc. 137 (2015) 3017–3023.
26] S. Luo, X. Tan, S. Fang, et al., Adv. Funct. Mater. 26 (2016) 2826–2835.
27] X. Tan, S. Luo, L. Long, et al., Adv. Mater. 29 (2017) 1704196.
[
[28] C. Wu, X. Huang, Y. Tang, et al., Chem. Commun. 55 (2019) 790–793.
[29] P. Liang, Q. Tang, Y. Cai, et al., Chem. Sci. 8 (2017) 7457–7463.
[
[
[
30] Y. Jiang, J. Li, X. Zhen, C. Xie, K. Pu, Adv. Mater. 30 (2018) 1705980.
31] C. Yang, X. Wang, S. Huang, M. Wang, Adv. Funct. Mater. 28 (2018) 1705226.
32] L. Shi, F. Hu, Y. Duan, et al., ACS Nano 14 (2020) 2183–2190.
[33] D. Chen, Q. Tang, J. Zou, et al., Adv. Healthc. Mater. 7 (2018) 1701272.
Declaration of competing interest
[34] Y. Tang, L. Xue, Q. Yu, et al., ACS Appl. Bio Mater. 2 (2019) 5888–5897.
[35] Q. Tang, W. Xiao, C. Huang, et al., Chem. Mater. 29 (2017) 5216–5224.
[36] W. Lin, D. Colombani-Garay, L. Huang, C. Duan, G. Han, WIREs Nanomed.
Nanobiotechnol. 12 (2020) 1–15.
The authors declare that they have no known competing
financial interests or personal relationships that could have
appeared to influence the work reported in this paper.
[
37] S. Li, Q. Deng, Y. Zhang, et al., Adv. Mater. 32 (2020) 2001146.
[38] J. Li, D. Cui, J. Huang, et al., Angew. Chem. 58 (2019) 12680–12687.
[39] D. Chen, Q. Yu, X. Huang, et al., Small 16 (2020) 2001059.
[40] D. Chen, Z. Wang, H. Dai, et al., Small Methods 4 (2020) 2000013.
Acknowledgments
[
41] Z. Zhang, W. Xu, M. Kang, et al., Adv. Mater. 32 (2020) 2003210.
42] K. Wang, W. Ma, Y. Xu, et al., Chin. Chem. Lett. 31 (2020) 3149–3152.
[43] R. Boyd, Nat. Chem. 3 (2011) 570.
[
The work was supported by Natural Science Foundation of
Jiangsu Province (No. BK20200092), National Natural Science
Foundation of China (No. 52072172), Six Talent Peak Innovation
Team in Jiangsu Province (No. TD-SWYY-009). We are also grateful
[44] G. Mugesh, H.B. Singh, Chem. Soc. Rev. 29 (2000) 347–357.
[45] Q. Wu, Y. Yuan, F. Chen, et al., ACS Macro Lett. 9 (2020) 1547–1551.
[46] C. Sun, Y. Tan, H. Xu, ACS Mater. Lett. 2 (2020) 1173–1177.
[47] J. Yang, S. Pan, S. Gao, Y. Dai, H. Xu, Biomaterials 249 (2020) 120054.
1584